Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

September 01, 1992; Volume 42,Issue 3
  • You have access
    Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter.
    B Giros, S el Mestikawy, N Godinot, K Zheng, H Han, T Yang-Feng and M G Caron
    Molecular Pharmacology September 1992, 42 (3) 383-390;
  • You have access
    Immunological identification of A2 adenosine receptors by two antipeptide antibody preparations.
    T M Palmer, K A Jacobson and G L Stiles
    Molecular Pharmacology September 1992, 42 (3) 391-397;
  • You have access
    Agonist binding to rat brain somatostatin receptors alters the interaction of the receptors with guanine nucleotide-binding regulatory proteins.
    S F Law and T Reisine
    Molecular Pharmacology September 1992, 42 (3) 398-402;
  • You have access
    Characterization of rat white fat cell alpha 1B-adrenoceptors.
    M E Torres-Márquez, M T Romero-Avila, C González-Espinosa and J A García-Sáinz
    Molecular Pharmacology September 1992, 42 (3) 403-406;
  • You have access
    Stimulation of high affinity gamma-aminobutyric acidB receptors potentiates the depolarization-induced increase of intraneuronal ionized calcium content in cerebellar granule neurons.
    G De Erausquin, G Brooker, E Costa and W J Wojcik
    Molecular Pharmacology September 1992, 42 (3) 407-414;
  • You have access
    Chronic ethanol administration alters gamma-aminobutyric acidA receptor gene expression.
    M C Mhatre and M K Ticku
    Molecular Pharmacology September 1992, 42 (3) 415-422;
  • You have access
    Gate-dependent blockade of sodium channels by phenothiazine derivatives: structure-activity relationships.
    V Bolotina, K R Courtney and B Khodorov
    Molecular Pharmacology September 1992, 42 (3) 423-431;
  • You have access
    Intrinsic activity determinations at the dopamine D2 guanine nucleotide-binding protein-coupled receptor: utilization of receptor state binding affinities.
    R A Lahti, L M Figur, M F Piercey, P L Ruppel and D L Evans
    Molecular Pharmacology September 1992, 42 (3) 432-438;
  • You have access
    Cloning and pharmacological characterization of a novel human 5-hydroxytryptamine1D receptor subtype.
    S A Veldman and M J Bienkowski
    Molecular Pharmacology September 1992, 42 (3) 439-444;
  • You have access
    Antagonist-induced transient down-regulation of delta-opioid receptors in NG108-15 cells.
    M M Belcheva, J Barg, C Gloeckner, X M Gao, D M Chuang and C J Coscia
    Molecular Pharmacology September 1992, 42 (3) 445-452;
  • You have access
    Different calcium-mobilizing receptors share the same guanine nucleotide-binding protein pool in hepatocytes.
    L L Dasso and C W Taylor
    Molecular Pharmacology September 1992, 42 (3) 453-457;
  • You have access
    Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor.
    M A Cascieri, E Ber, T M Fong, S Sadowski, A Bansal, C Swain, E Seward, B Frances, D Burns and C D Strader
    Molecular Pharmacology September 1992, 42 (3) 458-463;
  • You have access
    Regulation of the 5-hydroxytryptamine1B receptor in opossum kidney cells after exposure to agonists.
    C D Unsworth and P B Molinoff
    Molecular Pharmacology September 1992, 42 (3) 464-470;
  • You have access
    Ionic zinc may function as an endogenous ligand for the haloperidol-sensitive sigma 2 receptor in rat brain.
    M A Connor and C Chavkin
    Molecular Pharmacology September 1992, 42 (3) 471-479;
  • You have access
    Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    M Morissette, D Lévesque and T Di Paolo
    Molecular Pharmacology September 1992, 42 (3) 480-488;
  • You have access
    Inhibition of voltage-gated Ca2+ channels and insulin secretion in HIT cells by the Ca2+/calmodulin-dependent protein kinase II inhibitor KN-62: comparison with antagonists of calmodulin and L-type Ca2+ channels.
    G Li, H Hidaka and C B Wollheim
    Molecular Pharmacology September 1992, 42 (3) 489-488;
  • You have access
    Differential effects of ethanol on electrical properties of various potassium channels expressed in oocytes.
    V Anantharam, H Bayley, A Wilson and S N Treistman
    Molecular Pharmacology September 1992, 42 (3) 499-505;
  • You have access
    Stereochemical aspects of benzodiazepine binding to human serum albumin. I. Enantioselective high performance liquid affinity chromatographic examination of chiral and achiral binding interactions between 1,4-benzodiazepines and human serum albumin.
    T A Noctor, C D Pham, R Kaliszan and I W Wainer
    Molecular Pharmacology September 1992, 42 (3) 506-511;
  • You have access
    Stereochemical aspects of benzodiazepine binding to human serum albumin. II. Quantitative relationships between structure and enantioselective retention in high performance liquid affinity chromatography.
    R Kaliszan, T A Noctor and I W Wainer
    Molecular Pharmacology September 1992, 42 (3) 512-517;
  • You have access
    Nucleotide specificity of human deoxycytidine kinase.
    D S Shewach, K K Reynolds and L Hertel
    Molecular Pharmacology September 1992, 42 (3) 518-524;
  • You have access
    Metabolic pathways for the activation of the antiviral agent 2',3'-dideoxyguanosine in human lymphoid cells.
    L L Bondoc, G Ahluwalia, D A Cooney, N R Hartman, D G Johns and A Fridland
    Molecular Pharmacology September 1992, 42 (3) 525-530;
  • You have access
    Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity.
    N W Gibson, J A Hartley, J Butler, D Siegel and D Ross
    Molecular Pharmacology September 1992, 42 (3) 531-536;
  • You have access
    Cell-protecting effect against herpes simplex virus-1 and cellular metabolism of 9-(2-phosphonylmethoxyethyl)adenine in HeLa S3 cells.
    J Cerny, S A Foster and Y C Cheng
    Molecular Pharmacology September 1992, 42 (3) 537-544;
  • You have access
    Suggested mechanism for the modulation of the activity of NAD(P)H:quinone acceptor oxidoreductase (DT-diaphorase) by menadione: interpretation of the effect of menadione on 5'-[p-(Fluorosulfonyl)benzoyl]adenosine labeling of rat liver NAD(P)H:quinone acceptor oxidoreductase.
    S Chen and X F Liu
    Molecular Pharmacology September 1992, 42 (3) 545-548;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 42, Issue 3
1 Sep 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Cardiac Safety of Doxorubicin
  • Wnt Signaling and Drug Resistance in Cancer
  • Salicylate Blocks Lipolytic Actions of Tumor Necrosis Factor-α in Primary Rat Adipocytes
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics